Cargando…
Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism
BACKGROUND: Perhaps no greater challenge exists for public health, patient safety, and shared global health security, than fake/falsified/fraudulent, poor quality unregulated drugs, also commonly known as “counterfeit medicines”, now endemic in the global drug supply chain. Counterfeit medicines are...
Autores principales: | Mackey, Tim K, Liang, Bryan A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225602/ https://www.ncbi.nlm.nih.gov/pubmed/24228892 http://dx.doi.org/10.1186/1741-7015-11-233 |
Ejemplares similares
-
Counterfeit Drug Penetration into Global Legitimate Medicine Supply Chains: A Global Assessment
por: Mackey, Tim K., et al.
Publicado: (2015) -
INCB, WHO AND UNODC STATEMENT ON ACCESS TO INTERNATIONALLY CONTROLLED MEDICINES DURING COVID-19 PANDEMIC
Publicado: (2020) -
Combating healthcare corruption and fraud with improved global health governance
por: Mackey, Tim K, et al.
Publicado: (2012) -
Electronic solutions for combating counterfeit drugs
por: Hemalatha, R., et al.
Publicado: (2015) -
An exploration of counterfeit medicine surveillance strategies guided by geospatial analysis: lessons learned from counterfeit Avastin detection in the US drug supply chain
por: Cuomo, Raphael E, et al.
Publicado: (2014)